Get started

Stocktrading

ITI for Swing/Positional ViewITI Prediction for Swing/ Posional Trading First trendline breakout at Entry 1 level. You can entry at Entry 1 level above 125.5 but there is a resistance 132-134 level. You can enter in trade at Entry 2 level above 134 close daily basis or you can entry at any of the above levels according to your experience. SLs- 122,118,112( according to your entry and RRR) Targets- 144,165,197,250,… Intermediate Targets- 140,155,176,187,208,219,229,240,260,… According to your “STOMACH” book your profit. Always maintain your risk management. Watch Carefully – The Chart Explains For Itself. Can anyone tell me which chat patterns are shown up here? Disclaimer: I am not a SEBI Registered Analyst. Anything posted here is my own analysis and views. This is created for educational purposes only. Always consult your Financial Advisor before taking any decision or trade. Request: Please support by Like, follow, comment, share and boost. Happy trading. About ITI - ITI Ltd. engages in the business of manufacturing, trading, and servicing of telecommunications equipment and rendering other associated and ancillary services. It offers telecom products and total solutions covering the whole spectrum of switching, transmission, access, and subscriber premises equipment. The company was founded in 1948 and is headquartered in Bangalore, India. You can follow me in social media through links given below-
NSE:ITILong
by suraranjanganguli
Value Investing: STOCKS to watch in 2024Hi Traders, Investors and Speculators of Charts📈📉 Welcome to 2024🥂🥳 After great feedback from the altcoin list, I'll be doing a series on top stocks to watch for 2024, all in one post for your convenience! Stocks I'll focus on include: 📢 Undervalued stocks 📢 Stocks with great upside potential 📢 New stocks to watch I'll keep adding/updating one by one to the bottom of this post, so make sure you bookmark and follow! 1) AMEX:PSIL The AdvisorShares Psychedelics ETF (NYSE ticker: PSIL) invests in the emerging psychedelic drugs sector, offering exposure to those biotechnology, pharmaceutical and life sciences companies we see as leading the way in this nascent industry.
AMEX:PSILLong
by CryptoCheck-
2
CYBIN - The Mushroom Long Term Play Amidst my re-evaluation of markets, divestment from crypto, and future planning, I'm slowly building a long term position in CYBIN. As a therapist who also happens to be a fan of psychedelics, this one fits me well. I think it can continue to flounder around, and perhaps test some even lower levels. Just looking for optimal entry points now, and managed to scoop some up the other day at $0.50. Over the next 10 years, I think the psychedelic mushroom industry will be an interesting place for growth. Screw tech. Mushrooms all the way! And not just the magic ones. I'll be on the lookout for other companies as well, and should probably devote some more time to research. I placed some theoretical targets for this, since the company is currently valued just under $100M. I think $3 Billion is fairly conservative, hence the $15 target. This is meant for speculation only, and not as financial advice. -Victor Cobra
AMEX:CYBNLong
by VictorCobra
4
NIKE: On a key long term pivot and almost oversold.Nike is almost oversold on the 1D technical outlook (RSI = 33.787, MACD = -2.530, ADX = 53.733) and is trading sideways inside the P1 Zone, which is the Pivot Band that has started several rebounds inside this 1 year Triangle pattern. This isn't an automatic buy for us yet, we need to see the price crossing over the 1D MA50 before buying and aim at the LH trendline (TP = 119.00). If P1 breaks downwards, we will on the HL trendline and aim again at the LH trendline (TP = 119.00). ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
NYSE:NKE
by InvestingScope
GMDC LTD for Swing / Positional GMDC LTD Prediction for Swing / Positional Trading First breakout at Entry 1 level. Second breakout at Entry 2 Level above 228. This entry 2 may be retest. you can entry now and more buy on retesting. Volume also supports the breakout. SLs- 208, 185 Targets- 270,350,485,700,… Intermediate Targets - 239,249,259,269,279,290,300,320,340,360,372,383,402,435,445,495,505,515,535,548,570,……. According to your “STOMACH” book your profit. Always maintain your risk management. Watch Carefully – The Chart Explains For Itself. Can anyone tell me which chat patterns are shown up here? Disclaimer: I am not a SEBI Registered Analyst. Anything posted here is my own analysis and views. This is created for educational purposes only. Always consult your Financial Advisor before taking any decision or trade. Request: Please support by Like, follow, comment, share and boost. Happy trading. Always maintain your Risk Management. #TradingView #StockAnalysis #gmdc #TradeOpportunity About GMDC- Gujarat Mineral Development Corp. Ltd. (GMDC LTD) engages in the development of mineral resources. The firm operates through Mining and Power segments. Its products include lignite, bauxite, fluorspar, manganese, silica sand, limestone, bentonite, and ball clay. The company was founded on May 15, 1963 and is headquartered in Ahmedabad, India. You can follow me in social media through links given below-
NSE:GMDCLTDLong
by suraranjanganguli
1
S&P500 Next Support LevelClosely monitor the zone indicated in above chart. Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
SP:SPX
by rukshan2102
Cross-Checking News Trading with Technicals on CARR-USDDear Esteemed Investors, Everyone asked me to write an analytics on CARR. Although my forecasts achieved some success with this stock, let me remind you it's only a very small percentage of my portfolio. I can measure my exposure in hundreds of thousands, which is relatively small compared to my gold exposure, which I measure in millions. With that, I care about every one of my investments, and I hear your expectation to read analytics about this stock. Here you go. Chart and Technical Indicators CARR hit the target level of the last bullish forecast ($59.21 resistance), and technical indicators like MACD and RSI turned bearish. Under the chart, MACD shows bearish progress. Both MACD and RSI have a bearish cross on them. These are typical confirmations of resistance, and CARR hasn't defeated it yet. However, RSI still moves on the more bullish side of its chart, and MACD shows only a slight bearishness. It's not too late for CARR investors to continue the rally. Signs of continuation would be if RSI made a bullish cross again and MACD turned bullish. If they can break the mentioned resistance, a target of $61.12 is possible. With that said, the risk-reward ratio of a long isn't excellent here. So, I've taken profit of my long position from the last forecast. I estimate to open a new long if the price confirms support again around the $51.74 level. Breaking this support would suggest a downward trend rather than a healthy retracement. Downwards, the price can fall to lower trendlines below $48. If I open a new long, I'll use a tight stop loss setting. News Trading: AI Natural Language Processing Carrier Global has consistently delivered strong revenue growth in recent quarters, driven by higher demand for HVAC and refrigeration products. The company's recent acquisitions of Viessmann Climate Solutions and Honeywell's Global Access Solutions business expand its market reach and product portfolio. Carrier Global has a healthy balance sheet with a solid financial position. The company has the flexibility to invest in growth initiatives. The global HVAC and refrigeration markets can steadily in the coming years, driven by population growth, urbanization, and rising environmental concerns. On the other hand, the ongoing supply chain disruptions have impacted Carrier Global's production and delivery of products, potentially affecting sales and profitability. Escalating inflation could put downward pressure on consumer spending on discretionary items such as HVAC and refrigeration products. The HVAC and refrigeration industry is highly competitive, with several players vying for market share. The ongoing geopolitical tensions and potential for global recession could dampen demand for Carrier Global's products. Despite the potential headwinds, Carrier Global remains a well-positioned company with a strong track record of growth. The company's focus on innovation, strategic acquisitions, and expanding market reach should support its long-term growth prospects. However, investors should carefully monitor the company's ability to manage supply chain disruptions, inflation, and competitive pressures. Disclaimer: The success of my historic forecasts don't guarantee your future results. It's not an investment advice. Do your esearch. I wrote the analytics for entertainment purposes. Kind regards, Ely
NYSE:CARRLong
by Elysian_Mind
4
NETFLIX: This rebound isn't a buy opportunity.NFLX is staging a rebound on the 1D MA50 on a marginally bullish 1D technical outlook (RSI = 56.295, MACD = 4.710, ADX = 36.125). We don't consider this a buy opportunity as even if a slightly HH is made, the 1D RSI is showing a Bearish Divergence on a Channel Down, the same kind of bearish pattern that started the bearish waves in the two HH prior. Consequeantly we expect a pullback to at least the bottom of the Channel Up (dashed) or the HL trendline (which will be -25.25% from the top) depending on when the 1D RSI crosses under the 30.000 level (oversold), which was the buy trigger on the last two bottom opportunities. We have a long term TP = 550.00. See how our prior idea has worked: ## If you like our free content follow our profile to get more daily ideas. ## ## Comments and likes are greatly appreciated. ##
NASDAQ:NFLXShort
by InvestingScope
1
🔬💊 Amgen Innovations & Strategic Moves 🚀🌟 Lumakras Breakthrough: Amgen (AMGN) pioneers cancer treatment with Lumakras, the first medication targeting a mutation found in approximately 13% of lung cancer patients. 💰 Strategic Acquisition: Amgen acquires Horizon Therapeutics for a substantial $28 billion in cash. Incorporates Tepezza, an FDA-approved medicine for thyroid eye disease, into Amgen's product portfolio. 📈 Market Outlook: Bullish stance on AMGN suggests support levels above $260.00-$265.00. Anticipated upside target in the range of $360.00-$365.00. Exciting developments in biotech and strategic expansion for Amgen! 🌐💉 #AmgenInnovation #Biotech #StockMarket 📰📊
NASDAQ:AMGNLong
by Richtv_official
1